# Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)

> **NCT00951028** · NA · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 240 (actual)

## Conditions studied

- HIV
- Depression
- HIV Infections

## Interventions

- **BEHAVIORAL:** Cognitive behavioral therapy (CBT) for adherence and depression (CBT-AD)
- **BEHAVIORAL:** Life-steps adherence treatment
- **BEHAVIORAL:** Information and supportive psychotherapy (ISP) for adherence and depression (ISP-AD)

## Key facts

- **NCT ID:** NCT00951028
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2013-04
- **Final completion:** 2013-04
- **Target enrollment:** 240 (ACTUAL)
- **Last updated:** 2013-06-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00951028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00951028, "Therapy Targeting Depression and HIV Treatment Adherence (The TRIAD Study)". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00951028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*